$3.04
-0.29-8.71%
At close: -
$3.55
0.5116.78%
After Hours: Mar 24, 5:52 PM EDT
Comments
Loading...
OncoCyte Earnings Estimates, EPS & Revenue | NASDAQ:OCX | Benzinga
OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$0.000
Quarterly Revenue Estimate
$158.55K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$709.00K
Analyze the earnings history of OncoCyte using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCX | OncoCyte | -$1.13 | $0.00 | — | — | $176.00K | $158.55K | — | — | 05/14/2025 | Get Alert |
| OCX | OncoCyte | -$2.18 | $0.00 | -$0.25 | -100.00% | $314.00K | $101.67K | $1.49M | 1361.59% | 03/24/2025 | Get Alert |
| OCX | OncoCyte | -$0.50 | -$0.44 | -$0.41 | 6.82% | $429.00K | $200.00K | $115.00K | -42.50% | 11/12/2024 | Get Alert |
| OCX | OncoCyte | -$0.59 | -$0.56 | -$0.36 | 35.71% | $463.00K | $320.00K | $104.00K | -67.50% | 08/08/2024 | Get Alert |
| OCX | OncoCyte | $0.82 | -$0.67 | -$1.13 | -68.66% | $297.00K | $350.00K | $176.00K | -49.71% | 05/15/2024 | Get Alert |
| OCX | OncoCyte | — | -$1.14 | -$2.18 | -91.23% | — | $320.00K | $314.00K | -1.88% | 04/12/2024 | Get Alert |
| OCX | OncoCyte | -$1.60 | -$1.01 | -$0.50 | 50.50% | $1.02M | $330.00K | $429.00K | 30.00% | 11/09/2023 | Get Alert |
| OCX | OncoCyte | -$2.00 | -$0.87 | -$0.59 | 32.18% | $2.07M | $360.00K | $463.00K | 28.61% | 08/10/2023 | Get Alert |
| OCX | OncoCyte | -$2.40 | -$1.60 | -$1.40 | 1250.00% | $1.43M | $350.00K | $297.00K | -15.14% | 05/11/2023 | Get Alert |
| OCX | OncoCyte | -$1.20 | -$1.80 | — | — | $3.59M | $1.42M | — | — | 04/03/2023 | Get Alert |
| OCX | OncoCyte | — | -$2.20 | -$1.60 | 2727.27% | — | $1.48M | $1.02M | -31.28% | 11/10/2022 | Get Alert |
| OCX | OncoCyte | -$2.40 | -$2.20 | -$2.00 | 909.09% | $2.03M | $2.70M | $2.07M | -23.44% | 08/10/2022 | Get Alert |
| OCX | OncoCyte | -$1.00 | -$2.40 | -$2.20 | 833.33% | $1.12M | $2.24M | $1.43M | -36.38% | 05/11/2022 | Get Alert |
| OCX | OncoCyte | -$1.80 | -$2.60 | -$1.20 | 5384.62% | $503.00K | $3.63M | $3.59M | -1.13% | 03/10/2022 | Get Alert |
| OCX | OncoCyte | -$1.00 | -$2.40 | -$2.00 | 1666.67% | $555.00K | — | $984.00K | — | 11/09/2021 | Get Alert |
| OCX | OncoCyte | — | -$2.00 | -$2.60 | -3000.00% | — | $1.57M | $2.03M | 29.30% | 08/10/2021 | Get Alert |
| OCX | OncoCyte | -$2.60 | -$2.00 | -$1.00 | 5000.00% | $16.00K | $830.00K | $1.12M | 35.42% | 05/17/2021 | Get Alert |
| OCX | OncoCyte | -$3.00 | -$2.20 | -$1.80 | 1818.18% | $0.00 | $820.00K | $503.00K | -38.66% | 03/16/2021 | Get Alert |
| OCX | OncoCyte | -$2.00 | -$1.80 | -$2.00 | -1111.11% | $0.00 | $370.00K | $555.00K | 50.00% | 11/12/2020 | Get Alert |
| OCX | OncoCyte | -$2.00 | -$2.00 | -$2.80 | -4000.00% | $0.00 | $50.00K | $143.00K | 186.00% | 07/29/2020 | Get Alert |
| OCX | OncoCyte | -$1.60 | -$2.20 | -$2.60 | -1818.18% | $0.00 | — | $16.00K | — | 05/12/2020 | Get Alert |
OncoCyte (OCX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-24 | $-0.25 | $0 | -100.0 % |
| Q3 | 2024-11-12 | $-0.41 | $-0.44 | 6.82 % |
| Q2 | 2024-08-08 | $-0.36 | $-0.56 | 35.7 % |
| Q1 | 2024-05-15 | $-1.13 | $-0.67 | -68.7 % |
OncoCyte (OCX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-24 | $1.49M | $101.67K | 1361.6 % |
| Q3 | 2024-11-12 | $115.00K | $200.00K | -42.5 % |
| Q2 | 2024-08-08 | $104.00K | $320.00K | -67.5 % |
| Q1 | 2024-05-15 | $176.00K | $350.00K | -49.7 % |
FAQ
When is OncoCyte (NASDAQ:OCX) reporting earnings?
OncoCyte (OCX) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 24, 2025 for Q4.
What were the latest earnings per share (EPS) for OncoCyte (NASDAQ:OCX)?
The Actual EPS was $-0.25, which missed the estimate of $0.00.
What were OncoCyte’s (NASDAQ:OCX) revenues?
The Actual Revenue was $1.5M, which beat the estimate of $101.7K.
Browse earnings estimates, EPS, and revenue on all stocks.